Literature DB >> 34623517

Intra- and peritumoral radiomics on assessment of breast cancer molecular subtypes based on mammography and MRI.

Shuxian Niu1, Wenyan Jiang2, Nannan Zhao3, Tao Jiang1, Yue Dong3, Yahong Luo3, Tao Yu4, Xiran Jiang5.   

Abstract

PURPOSE: This study aimed to investigate the efficacy of digital mammography (DM), digital breast tomosynthesis (DBT), diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) MRI separately and combined in the prediction of molecular subtypes of breast cancer.
METHODS: A total of 241 patients were enrolled and underwent breast MD, DBT, DW and DCE scans. Radiomics features were calculated from intra- and peritumoral regions, and selected with least absolute shrinkage and selection operator (LASSO) regression to develop radiomics signatures (RSs). Prediction performance of intra- and peritumoral regions in the four modalities were evaluated and compared with area under the receiver-operating characteristic (ROC) curve (AUC), specificity and sensitivity as comparison metrics.
RESULTS: The RSs derived from combined intra- and peritumoral regions improved prediction AUCs compared with those from intra- or peritumoral regions alone. DM plus DBT generated better AUCs than the DW plus DCE on predicting Luminal A and Luminal B in the training (Luminal A: 0.859 and 0.805; Luminal B: 0.773 and 0.747) and validation (Luminal A: 0.906 and 0.853; Luminal B: 0.807 and 0.784) cohort. For the prediction of HER2-enriched and TN, the DW plus DCE yielded better AUCs than the DM plus DBT in the training (HER2-enriched: 0.954 and 0.857; TN: 0.877 and 0.802) and validation (HER2-enriched: 0.974 and 0.907; TN: 0.938 and 0.874) cohort.
CONCLUSIONS: Peritumoral regions can provide complementary information to intratumoral regions for the prediction of molecular subtypes. Compared with MRI, the mammography showed higher AUCs for the prediction of Luminal A and B, but lower AUCs for the prediction of HER2-enriched and TN.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Breast; MRI; Mammography; Molecular subtype; Radiomics

Mesh:

Year:  2021        PMID: 34623517     DOI: 10.1007/s00432-021-03822-0

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  37 in total

1.  Comparative study in patients with microcalcifications: full-field digital mammography vs screen-film mammography.

Authors:  U Fischer; F Baum; S Obenauer; S Luftner-Nagel; D von Heyden; R Vosshenrich; E Grabbe
Journal:  Eur Radiol       Date:  2002-04-19       Impact factor: 5.315

2.  Additional findings at preoperative breast MRI: the value of second-look digital breast tomosynthesis.

Authors:  Paola Clauser; Luca A Carbonaro; Martina Pancot; Rossano Girometti; Massimo Bazzocchi; Chiara Zuiani; Francesco Sardanelli
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

3.  Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRI.

Authors:  Basak E Dogan; Ana Maria Gonzalez-Angulo; Michael Gilcrease; Mark J Dryden; Wei Tse Yang
Journal:  AJR Am J Roentgenol       Date:  2010-04       Impact factor: 3.959

4.  Sonographic correlations with the new molecular classification of invasive breast cancer.

Authors:  I T H Au-Yong; A J Evans; S Taneja; E A Rakha; A R Green; C Paish; I O Ellis
Journal:  Eur Radiol       Date:  2009-05-14       Impact factor: 5.315

Review 5.  Correlation between imaging and molecular classification of breast cancers.

Authors:  M Boisserie-Lacroix; G Hurtevent-Labrot; S Ferron; N Lippa; H Bonnefoi; G Mac Grogan
Journal:  Diagn Interv Imaging       Date:  2013-07-15       Impact factor: 4.026

6.  NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2.

Authors:  Louis Fehrenbacher; Reena S Cecchini; Charles E Geyer; Priya Rastogi; Joseph P Costantino; James N Atkins; John P Crown; Jonathan Polikoff; Jean-Francois Boileau; Louise Provencher; Christopher Stokoe; Timothy D Moore; André Robidoux; Patrick J Flynn; Virginia F Borges; Kathy S Albain; Sandra M Swain; Soonmyung Paik; Eleftherios P Mamounas; Norman Wolmark
Journal:  J Clin Oncol       Date:  2019-12-10       Impact factor: 44.544

7.  Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.

Authors:  Nathaniel M Braman; Maryam Etesami; Prateek Prasanna; Christina Dubchuk; Hannah Gilmore; Pallavi Tiwari; Donna Plecha; Anant Madabhushi
Journal:  Breast Cancer Res       Date:  2017-05-18       Impact factor: 6.466

8.  BI-RADS 3-5 microcalcifications can preoperatively predict breast cancer HER2 and Luminal a molecular subtype.

Authors:  DongZhi Cen; Li Xu; Ningna Li; Zhiguang Chen; Lu Wang; Shuqin Zhou; Biao Xu; Chun Ling Liu; Zaiyi Liu; Tingting Luo
Journal:  Oncotarget       Date:  2017-02-21

9.  Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer.

Authors:  Ming Fan; Hui Li; Shijian Wang; Bin Zheng; Juan Zhang; Lihua Li
Journal:  PLoS One       Date:  2017-02-06       Impact factor: 3.240

10.  Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)-Positive Breast Cancer.

Authors:  Nathaniel Braman; Prateek Prasanna; Jon Whitney; Salendra Singh; Niha Beig; Maryam Etesami; David D B Bates; Katherine Gallagher; B Nicolas Bloch; Manasa Vulchi; Paulette Turk; Kaustav Bera; Jame Abraham; William M Sikov; George Somlo; Lyndsay N Harris; Hannah Gilmore; Donna Plecha; Vinay Varadan; Anant Madabhushi
Journal:  JAMA Netw Open       Date:  2019-04-05
View more
  2 in total

1.  Potential of the Non-Contrast-Enhanced Chest CT Radiomics to Distinguish Molecular Subtypes of Breast Cancer: A Retrospective Study.

Authors:  Fei Wang; Dandan Wang; Ye Xu; Huijie Jiang; Yang Liu; Jinfeng Zhang
Journal:  Front Oncol       Date:  2022-03-21       Impact factor: 6.244

2.  A deep learning approach with subregion partition in MRI image analysis for metastatic brain tumor.

Authors:  Jiaxin Shi; Zilong Zhao; Tao Jiang; Hua Ai; Jiani Liu; Xinpu Chen; Yahong Luo; Huijie Fan; Xiran Jiang
Journal:  Front Neuroinform       Date:  2022-08-03       Impact factor: 3.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.